ConductScience.org, home

Paper11568993

Efficacy and safety of aerosolized tobramycin in cystic fibrosis.

Pai VB and 1 other. Pediatr Pulmonol, 2001. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and safety of aerosolized tobramycin in cystic fibrosis. Papers, record 11568993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11568993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and safety of aerosolized tobramycin in cystic fibrosis.
PubMed
Journal
Pediatr Pulmonol
PubMed
Year
2001
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
1.83
iCite
Revised in PubMed
2022-04-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pai VBV B
2Nahata MCM C

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
TobramycinMajor topic
Administration, Inhalation
Adolescent
Aerosols
Biological Availability
Child
Child, Preschool
Consumer Product Safety
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Male
Nebulizers and Vaporizers
Sensitivity and Specificity
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42554208Genome-wide network of antibiotic susceptibility in Pseudomonas aeruginosa.J Antimicrob Chemother2026https://conductscience.org/library/papers/42554208PubMed
38651896Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection.mBio2024https://conductscience.org/library/papers/38651896PubMed
35281576N-Acetyl-Cysteine Increases Activity of Peanut-Shaped Gold Nanoparticles Against Biofilms Formed by Clinical Strains of Pseudomonas aeruginosa Isolated from Sputum of Cystic Fibrosis Patients.Infect Drug Resist2022https://conductscience.org/library/papers/35281576PubMed
34112170In vitro delivery efficiencies of nebulizers for different breathing patterns.Biomed Eng Online2021https://conductscience.org/library/papers/34112170PubMed
32671191Mode of nitric oxide delivery affects antibacterial action.ACS Biomater Sci Eng2020https://conductscience.org/library/papers/32671191PubMed
31360698Reducing the frequency of respiratory tract infections in severe neurological disorders by inhaled antibiotics: a retrospective data analysis.ERJ Open Res2019https://conductscience.org/library/papers/31360698PubMed
29904366Bilateral Vestibular Weakness.Front Neurol2018https://conductscience.org/library/papers/29904366PubMed
29517998Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis.Pharmaceuticals (Basel)2018https://conductscience.org/library/papers/29517998PubMed
29066797Destination of aminoglycoside antibiotics in the 'post-antibiotic era'.J Antibiot (Tokyo)2017https://conductscience.org/library/papers/29066797PubMed
27716346Fundamentals of aerosol therapy in critical care.Crit Care2016https://conductscience.org/library/papers/27716346PubMed
24673698Inhaled antibiotics for lower airway infections.Ann Am Thorac Soc2014https://conductscience.org/library/papers/24673698PubMed
22919396Sinonasal manifestations in cystic fibrosis.Int J Otolaryngol2012https://conductscience.org/library/papers/22919396PubMed
22028649Fitness landscape of antibiotic tolerance in Pseudomonas aeruginosa biofilms.PLoS Pathog2011https://conductscience.org/library/papers/22028649PubMed
21357290Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21357290PubMed
19395021The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies.Biomaterials2009https://conductscience.org/library/papers/19395021PubMed
19184617Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency.Pharm Res2009https://conductscience.org/library/papers/19184617PubMed
19129758Pulmonary fibrosis: pathogenesis, etiology and regulation.Mucosal Immunol2009https://conductscience.org/library/papers/19129758PubMed
18824604Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18824604PubMed
17536870Clinical pharmacology study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi.Paediatr Drugs2007https://conductscience.org/library/papers/17536870PubMed
14609360Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.Drugs2003https://conductscience.org/library/papers/14609360PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11568993

GET https://conductscience.org/api/papers/v1/11568993/authors